Background Image
Table of Contents Table of Contents
Previous Page  438 / 1498 Next Page
Information
Show Menu
Previous Page 438 / 1498 Next Page
Page Background

In the United States RT is less commonly used in the management HL

the consequences

With the use of PET scans upstaging to stages III/IV is not uncommon;

hence less RT is used

How have radiotherapists optimized treatment?

When administered, Radiation fields are smaller (IF-RT) and doses are lower than in past

decades

More than 2/3 of women do not need axillary irradiation, resulting in minimal (<10%) or no

breast exposure

Bulk decrease by chemotherapy and the benefit of modern imaging allows further

radiation field reduction (mediastinum)

Radiation dose has been cut back from >40 Gy to 30 Gy and more recently to 20 Gy (50%

reduction

For unfavorable and bulky stage II HL too many physicians forget that the

relapse rate is higher with chemotherapy alone compared to CMT; most

failures occur in sites of previous nodal disease!

Most patients who fail chemotherapy alone are still HIGHLY

curable but now they need HDT

Can this paradigm change?